Broker's call: Crisil (Sell)

| Updated on July 23, 2021

Centrum Broking

Crisil (Sell)

Target: ₹2,554

CMP: ₹3,059.85

Crisil’s Q2-CY21 earnings came in as expected. Revenue was bit lower while employee cost was a tad higher that led to a miss on core EBIT by 7.5 per cent. This was offset by better other income and lower tax which led to PAT in-line. Ratings saw a weak quarter led by a soft Q1 for the domestic economy while research saw good traction led by global, buy-side and domestic growth.

The MD & CEO, Ashu Suyash, has resigned and September 30 would be her last day. Amish Mehta, COO would succeed for a period of 5 years. He has over two decades of diverse experience across sectors. Mr. Mehta is a CA and a commerce graduate.

Although, North America contributes 41.3 per cent to revenues and the US economy is slated for a good about 6.5 per cent GDP growth in CY21, the recent run-up in Crisil led by better domestic and global economic prospects, translates to lofty valuations of 53.2x (5-year average at 37x).

Crisil may be a beneficiary of a probable global economic rebound, but this may be priced in, given the recent run-up, turning valuations steep.

Revise rating to Sell but raise PE multiple to 43.3x CY22 EPS. Change target price to ₹2,554.

Published on July 24, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like